Literature DB >> 6194547

Effects of progesterone derivatives on sodium pump activity and force of myocardial contraction in isolated guinea pig heart.

K Temma, Y C Ng, T M Brody, T Akera.   

Abstract

A progesterone derivative, chlormadinone acetate, has been reported to inhibit isolated Na,K-ATPase, to increase intracellular sodium, to decrease the force of myocardial contraction and to antagonize the positive inotropic action of ouabain. Because several inhibitors of isolated Na,K-ATPase fail to interact with the sodium pump in intact cells, two progesterone derivatives, chlormadinone acetate and megestrol acetate were examined for their effects on Na,K-ATPase, sodium pump activity and the force of contraction in isolated guinea pig atria. Both megestrol acetate and chlormadinone acetate inhibited specific (ATP-dependent) 3H-ouabain binding to Na,K-ATPase isolated from guinea pig brain or heart, with a corresponding inhibition of enzyme activity. The effects on Na,K-ATPase obtained from brain were more pronounced than that obtained from heart. The inhibitory effect of megestrol acetate was partially antagonized by K+. In electrically stimulated left atrial muscle preparations, neither compound affected ouabain-sensitive 42K+ uptake. Additionally, these compounds failed to affect the force of myocardial contraction or to influence the positive inotropic action of ouabain. These data fail to support the contention that inhibition of the sarcolemmal sodium pump is unrelated to the ouabain-induced increase in the force of myocardial contraction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194547

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  1 in total

1.  14 beta-Hydroxyprogesterone binds to the digitalis receptor, inhibits the sodium pump and enhances cardiac contractility.

Authors:  D Bose; D Elliott; T Kobayashi; J F Templeton; V P Kumar; F S LaBella
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.